Evaluation of mannitol effect in patients with acute hepatic failure and acute-on-chronic liver failure using conventional MRI, diffusion tensor imaging and in-vivo proton MR spectroscopy

World Journal of Gastroenterology

Volumn 14, Issue 26, 2008, Pages 4168-4178

  Saraswat, Vivek A ^a   Saksena, Sona ^a   Nath, Kavindra ^a   Mandal, Pranav ^a   Singh, Jitesh ^b   Thomas, M Albert ^c   Rathore, Ramkishore S ^b   Gupta, Rakesh K ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute liver failure; Acute on chronic liver failure; Diffusion tensor imaging; Mannitol; Proton MR spectroscopy

Indexed keywords

MANNITOL;

ADOLESCENT; ADULT; ARTICLE; BRAIN SIZE; BRAIN WATER; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DRUG EFFECT; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; IN VIVO STUDY; INTRACRANIAL PRESSURE; LIVER FAILURE; MALE; METABOLITE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OSMOSIS; PARENCHYMA; PROTON NUCLEAR MAGNETIC RESONANCE; VOLUNTEER; BRAIN; CHRONIC DISEASE; DIFFUSION WEIGHTED IMAGING; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

ADOLESCENT; ADULT; BRAIN; CHRONIC DISEASE; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER FAILURE, ACUTE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MANNITOL; MIDDLE AGED;

EID: 54049154394     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.4168     Document Type: Article

References (47)

1. Bauer M, Winning J, Kortgen A. Liver failure. Curr Opin Anaesthesiol 2005; 18: 111-116
2. Sass DA, Shakil AO. Fulminant hepatic failure. Liver Transpl 2005; 11: 594-605
3. Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif 2002; 20: 252-261
4. Vaquero J, Fontana RJ, Larson AM, Bass NM, Davern TJ, Shakil AO, Han S, Harrison ME, Stravitz TR, Munoz S, Brown R, Lee WM, Blei AT. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11: 1581-1589
5. Jalan R. Pathophysiological basis of therapy of raised intracranial pressure in acute liver failure. Neurochem Int 2005; 47: 78-83
6. Vaquero J, Chung C, Cahill ME, Blei AT. Pathogenesis of hepatic encephalopathy in-acute liver failure. Semin Liver Dis 2003; 23: 259-269.
7. Wright G, Jalan R. Management of hepatic encephalopathy in patients with cirrhosis. Best Pract Res Clin Gastroenterol 2007; 21;95-110
8. Diringer MN, Zazulia AR. Osmotic therapy: fact and fiction. Neurocrit-Care 2004; 1: 219-233
9. Bruce DA, Berman WA, Schut L. Cerebrospinal fluid pressure monitoring in children: physiology, pathology and clinical usefulness. Adv Pediatr 1977; 24: 233-290
10. Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut 1982; 23: 625-629
11. Videen TO, Zazulia AR, Manno EM, Derdevn CP, Adams RE, Diringer MN, Powers WJ. Mannitol Dolus preferentially shrinks non-infarcted brain in patients with ischemic stroke. Neurology 2001; 57: 2120-2122
12. Hartwell RC, Sutton LN. Mannitol, intracranial pressure, and vasogenic edema. Neurosurgery 1993; 32: 444-450; discussion 450
13. Cascino T, Baglivo J, Conti J, Szewczykowski J, Posner JB, Rottenberg DA. Quantitative CT assessment of furosemide-and mannitol-induced changes in brain water content Neurology 1983; 33: 898-903
14. Bell BA, Smith MA, Kean DM, Mcghee CN, MacDonald HL, Miller JD, Barnett GH, Tocher JL, Douglas RH, Best JJ. Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone. Lancet 1987; 1: 66-69
15. Grover VP, Dresner MA, Forton DM, Counsell S, Larkman DJ, Patel N, Thomas HC, Taylor-Robinson SD. Current and future applications of magnetic resonance imaging and spectroscopy of the brain in hepatic encephalopathy. World J Gastpoenterol 2006; 12: 2969-2978
16. Verma A, Saraswat VA, Radha Krishna Y, Nath K, Thomas MA, Gupta RK. In vivo (1)H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Liver Int 2008; Epub ahead of print
17. Cordoba. J, Gottstein J, Blei AT. Glutamine, myo-inositol, and organic brain osmolytes after portocaval anastomosis in the rat: implications for ammonia-induced brain edema. Hepatology 1996; 24: 919-923
18. Restuccia T, Gomez-Anson B, Guevara M, Alessandria C, Torre A, Alayrach ME, Terra C, Martín M, Castellvi M, Rami L, Sainz A, Ginès P, Arroyo V. Effects of dilutional hyponatremia on brain organic osmolytes and water content in patients with cirrhosis. Hepatology 2004; 39: 1613-1622
19. Le Bihan D. Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 2003; 4: 469-480
20. Stravitz RT, Kramer AH, Davern T, Shaikh AO, Caldwell SH, Mehta RL, Blei AT, Fontana RJ, McGuire BM, Rossaro L, Smith AD, Lee WM. Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver
21. Acharya SK, Dasarathy S, Kumer TE, Sushma S, Prasanna KS, Tandon A, Sreenivas V, Nijhawan S, Panda SK, Nanda SK, Irshad M, Joshi YK, Duttagupta S, Tandoh RK, Tandon BN. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 1996;. 3: 1448-1455
22. Bhatia V, Batra Y, Aeharva SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - a controlled clinical trial. J Hepatol 2004; 41: 89-96
23. Polson J, Lee WM. AASLD position paper: the management of acute liver failure. Hepatology 2005; 41: 1179-1197
24. Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol 1986; 2: 43-51.
25. Thomas MA, Huda A, Guze B, Curran J,. Bugbee M, Fairbanks L, Ke Y, Oshiro T, Martin P, Fawzy F. Cerebral 1H MR espectroscopy and neuropsychologic status of patients with hepatic encephalopathy. AJR Am J Roentgenol 1998; 171: 1123-1130
26. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14: 260-264
27. Le Bihan D. Diffusion and Perfusion Magnetic Resonance Imaging-Applications to functional MRI. New York: Raven Press Ltd, 1995
28. Hasan KM, Parker DL, Alexander AL. Comparison of gradient encoding schemes for diffusion-tensor MRI. J Magn Reson Imaging 2001; 13: 769-780
29. Woods RP, Mazziotta JC, Cherry, SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993; 17: 536-546
30. Purwar A, Gupta RK, Sarma MK, Bayu G, Singh A, Divya DKS, Saksena S, Trivedi R, Mishra AM, Haris M, Mohan P, Rathore RKS. De-scalping of the brain in echo planar DT-MRI. Proc International Society of Magnetic, Resonance in Medicine, 2006; 325
31. Hasan KM, Basser PJ, Parker DL, Alexander AL. Analytical computation of the eigenvalues and eigenvectors in DT-MRI. J Magn Reson 2001; 152: 41-47
32. Purwar A, Rathore DK, Rathore RKS, Gupta RK. A DTI analysis tool. Proc of European Society of Magnetic Resonance in Medicine, 2000:644 (Abstract number)
33. Cordoba J, Alonso J, Rovira A, Jacas C, Sanpedro F, Castells L, Vargas V, Margarit C, Kulisewsky J, Esteban R, Guardia J. The development of low-grade cerebral edema in cirrhosis is supported by the evolution of (l)H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598-604
34. Martinez-Hernandez A, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science 1977; 195: 1356-1358
35. Brusilow SW, Traystman R. Hepatic encephalopathy. N Engl J Med 1986; 314: 786-787; author reply 787
36. Lee WJ, Hawkins RA, Vina JR, Peterson DR. Glutamme transport by the blood-brain barrier: a possible mechanism for nitrogen removal. Am J Physiol 1998; 274: C1101-C1107
37. Record CO, Buxton B, Chase RA, Curzon G, Murray-Lyon IM, Williams R. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976; 6: 387-394
38. Norenberg, MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996; 16: 245-253.
39. Haussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Hennig J. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterology 1994; 107: 1475-1480
40. Blei AT, Larsen FS. Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 1999; 31: 771-776
41. Larsen FS. Optimal management of patients with tulminant hepatic failure: targeting the brain. Hepatology 2004; 39: 299-301
42. Rovira A, Grive E, Pedraza S, Rovira A, Alonso J. Magnetization transfer ratio values and proton MR spectroscopy of normal-appearing cerebral white matter in patients with liver cirrhosis. AJNR Am J Neuroradiol 2001; 22: 1137-1142
43. Rovira A, Cordoba J, Raguer N, Alonso J. Magnetic resonance imaging measurement of brain edema in patients with liver disease: resolution alter transplantation. Curr Opin Neutrol 2002; 15: 731-737
44. Saksena S, Rai V, Saraswat VA, Rathore RS, Purwar A, Kumar M, Thomas MA, Gupta RK. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure. J Gastroenterol Hepatol 2007
45. Nath K, Gupta RK, Trivedi R, Yellapu RK, Rai V, Saraswat VA, Purwar A, Rathore DKS, Rathore RKS. Diffusion tensor imaging in patients with acute-on-chronic liver failure. Proc International Society of Magnetic Resonance in Medicine, 2007: 675; Epub ahead of print
46. Wendon JA, Harrison PM, Keays R, Williams R. Cerebral blood flow and metabolism in fulminant liver failure. Hepatology 1994; 19: 1407-1413
47. Muizelaar JP, Lutz HA 3rd, Becker DP. Effect of mannitol on ICP and CBF and correlation with pressure autoregulation in severely head-injured patients. J Neurosurg 1984; 61: 700-706